Esperion Therapeutics, Inc. Annual Interest Expense in USD from 2011 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of the cost of borrowed funds accounted for as interest expense.
Summary: Esperion Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2011 to 2023.
Esperion Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $14M, a 2.52% decline year-over-year.
Esperion Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $58.6M, a 2.59% increase year-over-year.
Esperion Therapeutics, Inc. annual Interest Expense for 2023 was $59M, a 3.81% increase from 2022.
Esperion Therapeutics, Inc. annual Interest Expense for 2022 was $56.8M, a 22.6% increase from 2021.
Esperion Therapeutics, Inc. annual Interest Expense for 2021 was $46.4M, a 104% increase from 2020.

Interest Expense, Trailing 12 Months (USD)

Interest Expense, Annual (USD)

Interest Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$59M	+$2.17M	+3.81%	Jan 1, 2023	Dec 31, 2023	10-K	2024-02-27
2022	$56.8M	+$10.5M	+22.6%	Jan 1, 2022	Dec 31, 2022	10-K	2024-02-27
2021	$46.4M	+$23.7M	+104%	Jan 1, 2021	Dec 31, 2021	10-K	2023-02-21
2020	$22.7M	+$14.6M	+179%	Jan 1, 2020	Dec 31, 2020	10-K	2022-02-22
2019	$8.12M	+$8.09M	+28900%	Jan 1, 2019	Dec 31, 2019	10-K	2022-02-22
2018	$28K	-$170K	-85.9%	Jan 1, 2018	Dec 31, 2018	10-K	2021-02-23
2017	$198K	-$178K	-47.3%	Jan 1, 2017	Dec 31, 2017	10-K	2020-02-27
2016	$376K	-$144K	-27.7%	Jan 1, 2016	Dec 31, 2016	10-K	2018-02-20
2015	$520K	+$250K	+92.6%	Jan 1, 2015	Dec 31, 2015	10-K	2018-02-20
2014	$270K	-$666K	-71.2%	Jan 1, 2014	Dec 31, 2014	10-K	2017-02-22
2013	$936K	-$550K	-37%	Jan 1, 2013	Dec 31, 2013	10-K	2016-02-25
2012	$1.49M	+$909K	+157%	Jan 1, 2012	Dec 31, 2012	10-K	2015-03-10
2011	$577K			Jan 1, 2011	Dec 31, 2011	10-K	2014-03-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.